TY - JOUR
T1 - Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy
T2 - Using the Model for Improvement to impact Outcomes
AU - Kapadia, Malika
AU - Lehmann, Leslie
AU - Auletta, Jeffery
AU - Beatty, Lisa
AU - Bhatt, Neel
AU - Blacken, Robyn
AU - Demmel, Kathy
AU - Dodd, Therese
AU - Desmond, Catherine
AU - Fitch, Taylor
AU - Flesch, Laura
AU - Hartley, David
AU - Huber, John
AU - Ingraham, Hannah
AU - Jakubowski, Rita
AU - Klunk, Anna
AU - Krupski, Christa
AU - Kusnier, Katilyn
AU - Liberio, Nicole
AU - Maakaron, Joseph
AU - Mueller, Mark
AU - Myers, Kasiani C.
AU - Pai, Ahna
AU - Parker, Loretta
AU - Patel, Sagar
AU - Phelan, Rachel
AU - Polishchuk, Veronika
AU - Sigmund, Audrey
AU - Sper, Christine
AU - Tarquini, Sarah
AU - Juckett, Mark
AU - Jaglowski, Samantha
AU - Dandoy, Christopher
AU - Rotz, Seth
N1 - Funding Information:
Financial disclosure: None to report. Conflict of interest statement: There are no conflicts of interest to report. Authorship statement: The authors are members of a learning network (Transplant-Associated Learning Network Team or TALNT), consisting of clinicians, nurses, administrators, and patient caregivers from several pediatric and adult stem cell transplant institutions. The authors met regularly, and all contributed to the development and approval of the manuscript. Financial disclosure: See Acknowledgments on page 238.
Publisher Copyright:
© 2022 The American Society for Transplantation and Cellular Therapy
PY - 2022/5
Y1 - 2022/5
N2 - Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.
AB - Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.
UR - http://www.scopus.com/inward/record.url?scp=85126771134&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126771134&partnerID=8YFLogxK
U2 - 10.1016/j.jtct.2022.02.003
DO - 10.1016/j.jtct.2022.02.003
M3 - Review article
C2 - 35151937
AN - SCOPUS:85126771134
SN - 2666-6375
VL - 28
SP - 233
EP - 241
JO - Transplantation and Cellular Therapy
JF - Transplantation and Cellular Therapy
IS - 5
ER -